Tradestie Institutional Equity Comparison Engine

SXTP vs OKYO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OKYO Overall Edge

OKYO Captures Institutional Edge (2โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OKYO Pharma Limited Ordinary Shares (OKYO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, SXTP trades at N/M Forward P/E with -958.0% operating margin (-55.9% YoY revenue) versus OKYO at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SXTP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SXTP N/M vs OKYO N/M Fwd P/E
Growth & Margin Winner OKYO
Op Margin -958.0% vs 0.0% ยท YoY -55.9% vs +0.0%
Momentum & Technical Winner OKYO
1Y -55.4% vs -47.0% ยท 52W Pos 2% vs 3%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SXTP NASDAQ
60 Degrees Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$0.47
-6.36% 1D
Market Cap $2.2M
1M Return -46.55%
1Y Return -55.41%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 53.0 Fund 61.0 Flow 50.0 Mom 64.0
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SXTP -55.41% OKYO -47.03% Spread: +8.38 pp (OKYO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SXTP TTM Op. Margin: -958.0% OKYO TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SXTP vs OKYO. Trailing 12-month operating profitability (SXTP -958.0% vs OKYO 0.0%) and valuation multiples (SXTP N/M vs OKYO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SXTP (1) vs OKYO (6)
Institutional Metric SXTP OKYO Criterion Row Winner
Market Capitalization Scale $2.2M $62.7M Larger Scale OKYO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -55.9% +0.0% Higher Growth OKYO
Operating Margin (TTM) Profitability -958.0% 0.0% Higher Margin OKYO
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -327.4% -263.8% Higher ROE OKYO
52-Week Range Position Momentum 2% ($0โ€“$9) 3% ($1โ€“$3) Stronger Trend OKYO
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 160% Vol 1.00ฮฒ ยท 76% Vol Lower Realized Risk OKYO
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 42.8 / 100 (HOLD) Higher Composite SXTP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SXTP vs OKYO Buy Guide
SXTP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SXTP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SXTP nor OKYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.